News & Updates

Large lag between breast cancer symptom onset and clinical consultation in LMICs
Large lag between breast cancer symptom onset and clinical consultation in LMICs
18 Dec 2022
Study reinforces guideline to avoid prescribing EIASMs in glioma patients with epilepsy
Study reinforces guideline to avoid prescribing EIASMs in glioma patients with epilepsy
17 Dec 2022

First-line monotherapy with levetiracetam appears to have a more favourable effectiveness than enzyme-inducing antiseizure medications (EIASMs) in glioma patients with epilepsy, owing to lower treatment failure for any reason and better tolerability, according to a study, which supports the current neuro-oncology recommendations to avoid EIASMs in this population.

Study reinforces guideline to avoid prescribing EIASMs in glioma patients with epilepsy
17 Dec 2022